Joshua Allen
Direttore Tecnico/Scientifico/R&S presso CHIMERIX, INC.
Profilo
Joshua E.
Allen is currently the Chief Technology Officer at Chimerix, Inc. Prior to his current position, he served as the Chief Scientific Officer at Oncoceutics, Inc. from 2003 to 2021.
Dr. Allen holds a doctorate degree from the University of Pennsylvania.
Posizioni attive di Joshua Allen
| Società | Posizione | Inizio |
|---|---|---|
| CHIMERIX, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
Precedenti posizioni note di Joshua Allen
| Società | Posizione | Fine |
|---|---|---|
Oncoceutics, Inc.
 Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
Formazione di Joshua Allen
| University of Pennsylvania | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Oncoceutics, Inc.
Oncoceutics, Inc. Pharmaceuticals: MajorHealth Technology Oncoceutics, Inc. operates as a clinical-stage biopharmaceutical company. It is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The firm develops technology and therapies including ONC201, for natural potent tumor suppressor pathways in human cancer. Oncoceutics was founded by Wafik El-Deiry, Wolfgang Oster and Lee T. Schalop in 2009 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Joshua Allen
